Anatara Lifesciences CEO retires; interim named
Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Anatara Lifesciences Ltd. said Mel Bridges retired as CEO.
Executive director Tracie Ramsdale was named interim CEO.
Jay Hetzel, a nonexecutive director of Anatara, was also appointed interim chairman.
Brisbane, Australia-based Anatara Lifesciences develops nonantibiotic oral solutions for gastrointestinal diseases.